BioSpace News Archive

Executives share groundbreaking research on the use of longitudinal patient information to improve quality reporting at HIMSS 2018. [01-March-2018] TOPEKA, Kan., March 1, 2018 /PRNewswire/ -- Groundbreaking original research developed by the Kansas Health Information Network (KHIN) and Diameter Health now demonstrates the incontestable value health information

Q4 2017 Total Revenues of $183 Million. Q4 2017 Total Revenues of $183 Million.

CTP-543 on track to report topline Phase 2a results in Alopecia Areata by year-end.

HealtheConnections and eHealth Technologies find success with innovative solutions.

Global Phase 3 study to enroll approximately 100 patients with the most common genetic form of the disease.

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced it will report its fourth quarter and full year 2017 financial results and operational progress on Thursday, March 8, 2018, after the close of the U.S. financial markets.

U.S. Multi-Center Study Confirms Previous Intra-Procedural Safety; Post-TAVR Temporary Pacing Demonstrates Ambulation Capabilities

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of Eversense®, a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced the U.S. Food and Drug Administration (FDA) Clinical Chemistry and Clinical Toxicology Devices Panel is scheduled to review the premarket approval application (PMA) for Eversense on Thursday, March 29, 2018.

Three-year endeavor, Affordability Cures, aims to address root causes of high-cost health care system

New 10-hospital system includes the former East Texas Medical Center Regional Healthcare System and UT Health Northeast